Related Experiment Video
Updated: Aug 5, 2025

Author Spotlight: Efficiently Eliminating Bacteriophages from Infected Salmonella Cultures Using Lipopolysaccharides
Published on: June 28, 2024
ISOLATION AND CHARACTERIZATION OF BACTERIOPHAGE WITH LYTIC ACTIVITY AGAINST CARBAPENEM RESISTANCE STRAIN OF
Abeer Ameen Baqer1, Norefrina Shafinaz Md Nor2, Huda Salman Alagely3
1BIOTECHNOLOGY DIVISION, DEPARTMENTS OF APPLIED SCIENCES, UNIVERSITY OF TECHNOLOGY, IRAQ.
Objective:
Aim: Klebsiella pneumonia has emerged as an increasingly important cause of community-acquired nosocomial infections and many of these strains are highly virulent and exhibit a strong propensity to spread. Infections cause by K. pneumonia produces carbapen¬emase (KPC) enzyme and can be difficult to treat since only a few antibiotics are effective against them. Bacteriophage targeting this strain can be an alternative treatment. Characterisation of bacteriophage is utmost important in assisting the application of bacteriophage in phage therapy.
Patients And Methods:
Materials and methods: In the present study, the lytic bacteriophage, k3w7, isolated by the host Klebsiella pneumoniae kP2 was characterised using transmission electron microscope (TEM), plaque assay, and restriction digestive enzyme to investigate mor¬phology, host spectrum, bacteriophage life cycle and stability accordingly.
Results:
Results and conclusions: As shown by TEM, k3w7 was observed to have the characteristic of icosahedral heads 100 nm and contractile sheaths 120 nm suggesting it belongs to the family of myoviridae.The Investigation has done on the phage growth cycle showed a short latent period of 20 min and a burst size of approximately 220 plaque forming units per infected cell. Stability test showed the phage was stable over a wide range of pH and temperatures. According to restriction analysis, k3w7 had 50 -kb double-stranded DNA genome as well as the heterogeneous nature of genetic material. These findings suggest that K3W7 has a potential use in therapy against infections caused by K. pneumonia produces carbapenemase.
Insights
The lytic bacteriophage k3w7 shows potential for treating Klebsiella pneumoniae carbapenemase infections. This bacteriophage exhibits favorable characteristics for therapeutic applications against difficult-to-treat bacterial strains.
Area of Science:
- Microbiology
- Virology
- Infectious Diseases
Background:
- Klebsiella pneumoniae is a significant cause of hospital-acquired infections.
- Carbapenemase-producing K. pneumoniae strains are increasingly prevalent and difficult to treat.
- Bacteriophage therapy presents a promising alternative to antibiotics.
Purpose of the Study:
- To characterize the lytic bacteriophage k3w7 for potential therapeutic use.
- To evaluate the morphology, host range, life cycle, and stability of bacteriophage k3w7.
- To assess the suitability of k3w7 for combating carbapenemase-producing K. pneumoniae.
Main Methods:
- Isolation and characterization of bacteriophage k3w7 targeting Klebsiella pneumoniae kP2.
- Transmission Electron Microscopy (TEM) for morphology assessment.
- Plaque assays, restriction enzyme digestion, and stability tests (pH, temperature).
Main Results:
- TEM revealed k3w7 possesses icosahedral heads (100 nm) and contractile sheaths (120 nm), characteristic of the Myoviridae family.
- Phage growth cycle analysis showed a short latent period (20 min) and a burst size of ~220 PFU/cell.
- k3w7 demonstrated stability across a broad pH and temperature range, with a 50-kb double-stranded DNA genome.
Conclusions:
- Bacteriophage k3w7 exhibits robust characteristics suitable for phage therapy.
- Its stability and lytic activity make it a viable candidate against carbapenemase-producing K. pneumoniae.
- Further research into k3w7 could lead to novel treatments for multidrug-resistant infections.
Related Concept Videos
Lytic Cycle of Bacteriophages
Viral Replication: Lytic Cycle
Lysogenic Cycle of Bacteriophages
Viral Replication: Lysogenic Cycle

